FMED news

Fidelity Disruptive Medicine · Healthcare · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Seeking Alpha · 28 Oct 2026, 20:19 UTC
10x Genomics: Atera Takes Off, But Valuation Flies Too High (NASDAQ:TXG) | Seeking Alpha
5.2% of FMED
24/7 Wall St. · 28 Oct 2026, 22:00 UTC
Thermo Fisher Scientific Reaches $704 and a New 52-Week High
3.8% of FMED
News-Medical.net · 28 Oct 2026, 17:31 UTC
Hot-melt extrusion in pharmaceutical implant manufacturing
3.8% of FMED
Morningstar · 28 Oct 2026, 14:15 UTC
TMO - Thermo Fisher Scientific Inc Analysis
3.8% of FMED
Where to buy FMED
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
The Wall Street Journal · 28 Oct 2026, 20:17 UTC
Here's Why Moderna's CEO Isn't Fazed by Its Cancer-Vaccine Selloff
2.7% of FMED
Scienmag: Latest Science and Health News · 28 Oct 2026, 18:47 UTC
Nanopore Sequencing Delivers Full Pediatric Brain Tumor Workup in a Single
2.8% of FMED
Where to buy FMED
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
TheStreet · 28 Oct 2026, 19:33 UTC
Breakthrough cancer vaccine catches Wall Street's attention
2.7% of FMED
Seeking Alpha · 28 Oct 2026, 16:22 UTC
Moderna: ESMO Answered The Science, Q3 Has To Answer The Money (NASDAQ:MRNA) | Seeking Alpha
2.7% of FMED
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
2.7% of FMED
Benzinga · 26 Oct 2026, 17:27 UTC
Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year - Danaher (NYSE:DHR)
10.4% of FMED
The Manila times · 28 Oct 2026, 02:46 UTC
15-year-old Designs Low-Cost Device to Monitor Airborne Bacteria in the Environment; Wins $25,000 Top Award at the 2026 Thermo Fisher Scientific Junior Innovators Challenge
3.8% of FMED
Investing.com · 28 Oct 2026, 14:13 UTC
Why is Moderna stock rebounding today? By Investing.com
2.7% of FMED
Investing.com · 28 Oct 2026, 22:30 UTC
Intuitive Surgical EVP Mark Brosius sells $82,043 in company stock By Investing.com
2.0% of FMED
Seeking Alpha · 28 Oct 2026, 12:10 UTC
Fidelity Growth Company Fund Q3 2026 Commentary (FDGRX) | Seeking Alpha
2.7% of FMED
The Manila times · 27 Oct 2026, 20:21 UTC
Revolution Medicines to Participate in November 2026 Investor Conferences
2.9% of FMED
Seeking Alpha · 26 Oct 2026, 07:35 UTC
Baron Health Care Fund Q3 2026 Shareholder Letter (BHCFX) | Seeking Alpha
8.1% of FMED
Seeking Alpha · 28 Oct 2026, 13:49 UTC
UnitedHealth: Raised Premiums, Market Exits And Member Attrition Deliver Future Resilience | Seeking Alpha
1.6% of FMED
Quartz · 28 Oct 2026, 12:37 UTC
10 Medicare Advantage insurer ratings for 2027 across 4 categories
1.6% of FMED
The Boston Globe · 27 Oct 2026, 17:43 UTC
Moderna CEO on what's next after success in cancer vaccine
2.7% of FMED
The Boston Globe · 27 Oct 2026, 17:40 UTC
After a cancer vaccine's first success, the race is on to expand the impact
2.7% of FMED

FMED news

Where to buy FMED

Where to buy FMED